Maarten de Rooij
Overview
Explore the profile of Maarten de Rooij including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
1451
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Prive B, Govers T, Israel B, Janssen M, Timmermans B, Peters S, et al.
Eur J Nucl Med Mol Imaging
. 2025 Mar;
PMID: 40072531
Background: Prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) is currently under evaluation for detecting clinically significant prostate cancer. The PSMA-PET/CT may complement the current standard diagnostic pathway for...
2.
Barentsz J, Thijssen L, Moore C, de Rooij M
Eur Radiol
. 2025 Feb;
PMID: 39909900
No abstract available.
3.
Twilt J, Saha A, Bosma J, van Ginneken B, Bjartell A, Padhani A, et al.
Eur Urol
. 2024 Oct;
87(2):240-250.
PMID: 39438187
Background And Objective: Biparametric magnetic resonance imaging (bpMRI), excluding dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI), is a potential replacement for multiparametric MRI (mpMRI) in diagnosing clinically significant prostate cancer...
4.
Panebianco V, Briganti A, Efstathiou J, Galgano S, Luk L, Muglia V, et al.
Eur Urol
. 2024 Sep;
86(6):485-487.
PMID: 39317635
The American College of Radiology Vesical Imaging-Reporting and Data System (VI-RADS) Steering Committee will strive to ensure high-quality imaging practices for bladder cancer (BC) and improve outcomes for BC patients....
5.
6.
Bozgo V, Roest C, van Oort I, Yakar D, Huisman H, de Rooij M
Eur Radiol
. 2024 Jun;
34(12):7698-7704.
PMID: 38937295
Objective: To review the components of past and present active surveillance (AS) protocols, provide an overview of the current studies employing artificial intelligence (AI) in AS of prostate cancer, discuss...
7.
Saha A, Bosma J, Twilt J, van Ginneken B, Bjartell A, Padhani A, et al.
Lancet Oncol
. 2024 Jun;
25(7):879-887.
PMID: 38876123
Background: Artificial intelligence (AI) systems can potentially aid the diagnostic pathway of prostate cancer by alleviating the increasing workload, preventing overdiagnosis, and reducing the dependence on experienced radiologists. We aimed...
8.
de Rooij M, Allen C, Twilt J, Thijssen L, Asbach P, Barrett T, et al.
Eur Radiol
. 2024 May;
34(11):7068-7079.
PMID: 38787428
Multiparametric MRI is the optimal primary investigation when prostate cancer is suspected, and its ability to rule in and rule out clinically significant disease relies on high-quality anatomical and functional...
9.
Prive B, Israel B, Janssen M, van der Leest M, de Rooij M, van Ipenburg J, et al.
Radiology
. 2024 May;
311(2):e231879.
PMID: 38771185
Background Multiparametric MRI (mpMRI) is effective for detecting prostate cancer (PCa); however, there is a high rate of equivocal Prostate Imaging Reporting and Data System (PI-RADS) 3 lesions and false-positive...
10.
van Leeuwen K, Schalekamp S, Rutten M, Huisman M, Schaefer-Prokop C, de Rooij M, et al.
Radiology
. 2024 Jan;
310(1):e230981.
PMID: 38193833
Background Multiple commercial artificial intelligence (AI) products exist for assessing radiographs; however, comparable performance data for these algorithms are limited. Purpose To perform an independent, stand-alone validation of commercially available...